In conclusion, the impact and mechanism of PIK3CA gene mutation on tumor-associated antigen vaccines or cell therapy in colorectal cancer is complex, involving multiple aspects such as tumor cells, immune cells, signaling pathways, and the tumor microenvironment. This evidence concerns the gene PIK3CA and neoplasm.